Advertisement

Policy Updates

Wegovy is now approved to be used to reduce the risk of heart attack, stroke and cardiovascular death, which could lead to broader payer coverage of the drug. 

Advertisement

California legislators are putting a single-payer system back on the table, but it still faces long odds of becoming a reality, the Los Angeles Times reported Feb. 21. 

In 2024, Medicare Advantage plans must provide coverage for an inpatient admission when the admitting physician expects the patient to require hospital care for at least two midnights, otherwise known as the two-midnight rule.

Advertisement